Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021

Rhea-AI Summary

Blueprint Medicines Corporation (NASDAQ: BPMC) will host a live conference call on July 29, 2021 at 8:30 a.m. ET to disclose its second quarter 2021 financial results and provide a corporate update. Interested parties can join the call by dialing 844-200-6205 domestically or +44-208-0682-558 internationally, using conference ID 619159. A webcast will be accessible via the Investors & Media section on their website and will remain available for 30 days post-call. Blueprint Medicines focuses on developing targeted therapies for cancer and hematologic disorders.

Positive

• Blueprint Medicines is advancing multiple programs for genomically defined cancers.
• The company delivers approved medicines directly to patients in the U.S. and Europe.

Negative

• None.

CAMBRIDGE, Mass., July 22, 2021 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, July 29, 2021 to report its second quarter 2021 financial results and provide a corporate update.

To access the live conference call, please dial 844-200-6205 (domestic) or +44-208-0682-558 (international), and refer to conference ID 619159. A webcast of the call will also be available under "Events and Presentations" in the Investors & Media section of the Blueprint Medicines website at http://ir.blueprintmedicines.com/. The archived webcast will be available on Blueprint Medicines' website approximately two hours after the conference call and will be available for 30 days following the call.

About Blueprint Medicines

Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering approved medicines directly to patients in the United States and Europe, and we are globally advancing multiple programs for genomically defined cancers, systemic mastocytosis, and cancer immunotherapy.  For more information, visit www.BlueprintMedicines.com and follow us on Twitter (@BlueprintMeds) and LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021-301338751.html

SOURCE Blueprint Medicines Corporation

FAQ

When will Blueprint Medicines report its second quarter 2021 financial results?

Blueprint Medicines will report its second quarter 2021 financial results on July 29, 2021.

What time is the conference call for Blueprint Medicines' Q2 results?

The conference call will take place at 8:30 a.m. ET on July 29, 2021.

How can I access the Blueprint Medicines conference call?

You can access the conference call by calling 844-200-6205 domestically or +44-208-0682-558 internationally, with conference ID 619159.

Is there a way to listen to the Blueprint Medicines conference call after it occurs?

Yes, an archived webcast will be available on the Blueprint Medicines website approximately two hours after the call and will be accessible for 30 days.